Regulation of T-helper type 2 cell and airway eosinophilia by transmucosal coadministration of antigen and oligodeoxynucleotides containing CpG motifs

American Journal of Respiratory Cell and Molecular Biology

Volumn 22, Issue 2, 2000, Pages 176-182

  Shirota, Hidekazu ^a   Sano, Kunio ^a   Kikuchi, Tadashi ^a   Tamura, Gen ^a   Shirato, Kunio ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034040529     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.22.2.3772     Document Type: Article

References (41)

1. 1. Holt, P. G., and C. McMenamin. 1989. Defence againsl allergic sensitizalion in the healthy lung: the role of inhalation tolerance. Clin. Exp. Allergy 19: 255-262.
2. 2. Wheatley, L. M., and T. A. E. Platts-Mills. 1997. The role of allergens. In Asthma. P. J. Barnes, M. M. Grunstein, A. R. Leff, and A. J. Woolcock, editors. Lippincott-Raven Publishers, Philadelphia, PA. 1079-1087.
3. 3. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffery, D. J. Quint, and A. B. Key. 1991. Expression of mRNA for IL-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541-1546.
4. 4. Walker, C., J. C. Virchow, Jr., P. L. Bruijnzeel, and K. Blaser. 1991. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. 146:1829-1835.
5. 5. Bradley, B. L., M. Azzawi, M. Jacobson, B. Assoufi, J. V. Collins, A, M. Irani, L. B. Schwartz, S. R. Durham, P. K. Jeffery, and A. B. Kay. 1991. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J. Allergy Clin. Immunol 88:661-674.
6. 6. Robinson, D. S., Q. Hamid, S. Ying. A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
7. 7. Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blaser, and J. C. Virchow, Jr. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 145:109-115.
8. 8. Robinson, D. S., S. Ying, A. M. Bentley, Q. Meng, J. North, S. R. Durham, A. B. Kay, and Q. Hamid. 1993. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92:397-403.
9. + T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92:313-324.
10. + T cells. Immumol. Rev. 123:209-229.
11. 11. Erb, K. J., J. W. Holloway, A. Sobeck, H. Moll, and G. LeGros. 1998. Infection of mice with Mycobacterium bovis-bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. 187:561-569.
12. 12. Sano, K., K. Haneda, G. Tamura, and K. Shirato. 1999. Ovalbumin (OVA) and Mycobacterium tuberculosis bacilli cooperatively polarize anti-OVA T-helper (Th) cells toward a Th1-dominant phenotype and ameliorate murine tracheal eosinophilia. Am. J. Respir. Mol. Cell Biol. 20:1260-1267.
13. 13. Haneda, K., K. Sano, G. Tamura, T. Sato, S. Habu, and K. Shirato. 1997. TGF-β induced by oral tolerance ameliorates experimental tracheal eosinophilia. J. Immunol. 159:4484-4490.
14. + T cells ameliorates antigen-induced eosinophilic inflammation: novel high-dose tolerance in the trachea. Am. J. Respir. Cell Mol. Biol. 21:268-274.
15. 15. Klinman, D. M., A. K. Yi, S. L. Beaucage, J. Conover, and A. M. Krieg. 1996. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete IL-6, IL-12, and IFN-γ Proc. Natl. Acad. Sci. USA 93:2879-2883.
16. 16. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M. D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354.
17. 17. Chu, R. S., O. S. Targoni, A. M. Krieg, P. V. Lehmann, and C. V. Harding. 1997. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:1623-1631.
18. 18. Chace, J. H., N. A. Hooker, K. L. Mildenstein, A. M. Krieg, and J. S. Cowdery. 1997. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol. 84: 185-193.
19. 19. Lipford, G. B., M. Bauer, C. Blank, R. Reiter, H. Wagner, and K. Heeg. 1997. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur. J. Immunol. 27:2340-2344.
20. 20. Jakob, T., P. S. Walker, A. M. Krieg, M. C. Udey, and J. C. Vogel. 1998. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161:3042-3049.
21. 21. Sparwasser, T., E. S. Koch, R. M. Vabulas, K. Heeg, G. B. Lipford, J. W. Ellwart, and H. Wagner. 1998. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28:2045-2054.
22. 22. Weiner, G. J., H. M. Liu, J. E. Wooldridge, C. E. Dahle, and A. M. Krieg. 1997. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. USA 94:10833-10837.
23. 23. Zimmermann, S., O. Egeter, S. Hausmann, G. B. Lipford, M. Rocken, H. Wagner, and K. Heeg. 1998. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160:3627-3630.
24. 24. Sun, S., H. Kishimoto, and J. Sprent. 1998. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynuleotides to augment T cell responses to specific antigen. J. Exp. Med. 187:1145-1150.
25. 25. Broide, D., J. Schwarze, H. Tighe, T. Gifford, M. Nguyen, S. Malek, J. V. Uden, E. Martin-Orozco, E. W. Gelfand, and E. Raz. 1998. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161:7054-7062.
26. 26. Kline, J. N., T. J. Waldschmidt, T. R. Businga, J. E. Lemish, J. V. Weinstock, P. S. Thorne, and A. M. Krieg. 1998. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160:2555-2559.
27. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16:34-38.
28. 28. Gilkeson, G. S., P. Ruiz, A. M. M. Pippen, A. L. Alexander, J. B. Lefkowith, and D. S. Pisetsky. 1996. Modulation of renal disease in autoimmune NZB/ NZW mice by immunization with bacterial DNA. J. Exp. Med. 183:1389-1397.
29. 29. Mor, G., M. Singla, A. D. Steinberg, S. L. Hoffman, K. Okuda, and D. M. Klinman. 1997. Do DNA vaccines induce autoimmune disease? Hum. Gene Ther. 8:293-300.
30. 30. Krieg, A. M. 1995. CpG DNA: a pathogenic factor in systemic lupus erythematosus? J. Clin. Immunol. 15:284-292.
31. 31. Cowdery, J. S., J. H. Chace, A. Yi, and A. M. Krieg. 1996. Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156:4570-4575.
32. 32. Sarmiento, U. M., J. R. Perez, J. M. Becker, and R. Narayanan. 1994. In vivo toxicological effects of Rel A antisense phosphorothioates in CD-1 mice. Antisense Res. Dev. 4:99-107.
33. 33. Sparwasser, T., T. Miethke, G. Lipford, K. Borschert, H. Häcker, K. Heeg, and H. Wagner. 1997. Bacterial DNA causes septic shock. Nature 386:336-337.
34. 34. Sparwasser, T., T. Miethke, G. Lipford, A. Erdmann, H. Häcker, K. Heeg, and H. Wagner. 1997. Macrophages sense pathogens via DNA motifs: induction of TNF-α-mediated shock. Eur. J. Immunol. 27:1671-1679.
35. 35. Sano, K., I. Fujisawa, R. Abe, Y. Asano, and T. Tada. 1987. MHC-restricted minimal regulatory circuit initiated by a class II-autoreactive T cell clone. J. Exp. Med. 165:1284-1295.
36. 36. Kumagai, K., I. Ohno, S. Okada, Y. Ohkawara, K Suzuki, T. Shinya, H. Nagase, K. Iwata, and K. Shirato. 1999. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J. Immunol 162:4212-4219.
37. 37. Mead, J., and J. L. Whittenberger. 1953. Physical properties of human lungs measured during spontaneous respiration. J. Appl. Physiol. 5:779-796.
38. 38. Freimark, B. D., H. P. Blezinger, V. J. Florack, J. L. Nordstrom, S. D. Long. D. S. Deshpande, S. Nochumson, and K. L. Petrak. 1998. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes. J. Immunol. 160:4580-4586.
39. 39. Moldoveanu, Z., L. Love-Homan, W. Q. Huang, and A. M. Krieg. 1998. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16:1216-1224.
40. 40. McCluskie, M. J., and H. L. Davis. 1998. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol. 161:4463-4466.
41. 41. Sur, S., J. S. Wild, B. K. Choudhury, N. Sur, R. Alam, and D. M. Klinman. 1999. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 162:6284-6293.